Probable Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Negative Serum Antibodies in an Adolescent Male: Prompt Diagnosis and Long-Term Recovery
Academic and Clinical Pediatrics · 2026-05 · 3 (2) · 37-40
DOI: 10.4103/acped.acped_9_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic and Clinical Pediatrics, online erschienen am 27.08.2026. Verfasst von Stephanie Darda Susilowati und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In addition to a negative antibody test, a delayed availability of antibody test results may postpone treatment. Knowing when to start therapy improves prognosis. The aim of this report was to describe the clinical manifestation and result of early treatment prior to the result of the definitive diagnostic test of anti-NMDAR encephalitis. A 16-year-old previously healthy male was referred from psychiatry due to agitation, incoherent speech, and visual hallucinations, occurring 4 days after a generalized tonic–clonic nonfebrile seizure. The meningeal irritation sign was positive. Blood tests revealed peripheral neutrophilia. Head computed tomography showed cerebral edema and leptomeningeal enhancement (left parietal and bilateral Sylvian fissures), raising suspicion for meningoencephalitis. Electroencephalography (EEG) was normal. Neuropsychiatric symptoms continued despite the antiepileptic and acute psychosis treatment, consistent with probable anti-NMDAR encephalitis. Due to severe agitation, lumbar puncture was not possible, but serum tests for anti-NMDAR antibodies and other autoimmune markers were negative. The patient was treated with high-dose intravenous methylprednisolone and cyclophosphamide. Symptoms improved significantly after the first cycle of cyclophosphamide. The patient resumed school activity after 2 months of cyclophosphamide therapy and was involved in a national competition in a prestigious basketball league after 5 months of therapy. Five years posttherapy, the school and social ability were good, and emotional status was stable. This case emphasizes the importance of clinical diagnostic criteria in suspected anti-NMDAR encephalitis, particularly when confirmatory antibody testing is negative or unavailable. Early recognition and immunotherapy can result in excellent long-term recovery.
Zitieren
APA
Susilowati, S. D., Wati, K. D. K., Sutawan, I. B. R., Suwarba, I. G. N. M., & Wardani, I. A. K. (2026). Probable Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Negative Serum Antibodies in an Adolescent Male: Prompt Diagnosis and Long-Term Recovery. Academic and Clinical Pediatrics, 3(2), 37-40. https://doi.org/10.4103/acped.acped_9_25
Vancouver
Susilowati SD, Wati KDK, Sutawan IBR, Suwarba IGNM, Wardani IAK. Probable Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Negative Serum Antibodies in an Adolescent Male: Prompt Diagnosis and Long-Term Recovery. Academic and Clinical Pediatrics. 2026;3(2):37-40. doi:10.4103/acped.acped_9_25
BibTeX
@article{Susilowati2026,
author = {Susilowati, Stephanie Darda and Wati, Ketut Dewi Kumara and Sutawan, Ida Bagus Ramajaya and Suwarba, I Gusti Ngurah Made and Wardani, Ida Aju Kusuma},
title = {Probable Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Negative Serum Antibodies in an Adolescent Male: Prompt Diagnosis and Long-Term Recovery},
journal = {Academic and Clinical Pediatrics},
year = {2026},
volume = {3},
number = {2},
pages = {37--40},
doi = {10.4103/acped.acped_9_25}
}
EUVIMED